Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Martin K. Hunn"'
Autor:
Istafa J. Raza, Campbell A. Tingate, Panagiota Gkolia, Lorena Romero, Jin W. Tee, Martin K. Hunn
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Imaging-based monitoring of disease burden in glioma patients is frequently confounded by treatment effects. Circulating biomarkers could theoretically augment imaging-based response monitoring. This systematic review aimed to present and evaluate ev
Externí odkaz:
https://doaj.org/article/80b138d0584440d7ba586b3e1e2c0ed9
Autor:
Cameron S. Field, Martin K. Hunn, Peter M. Ferguson, Christiane Ruedl, Lindsay R. Ancelet, Ian F. Hermans
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Vaccine-mediated cancer treatment is unlikely to induce long-term survival unless suppressive mechanisms are overcome. Given the success of antibody-mediated immune checkpoint blockade in relieving regulation of endogenous anti-tumor T cell responses
Externí odkaz:
https://doaj.org/article/b0405e0c2f634b57a478c582d65f933c
Autor:
Zimeng Ye, Mark F. Bennett, Andrew Neal, Joshua A. Laing, Martin K. Hunn, Thanomporn Wittayacharoenpong, Marian Todaro, Sheila K. Patel, Melanie Bahlo, Patrick Kwan, Terence J. O'Brien, Ingrid E. Scheffer, Samuel F. Berkovic, Piero Perucca, Michael S. Hildebrand
Publikováno v:
Neurology. 99:1036-1041
Background and ObjectivesMosaic pathogenic variants restricted to the brain are increasingly recognized as a cause of focal epilepsies. We aimed to identify a mosaic pathogenic variant and its anatomical gradient in brain DNA derived from trace tissu
Publikováno v:
ANZ Journal of Surgery. 91:2568-2570
Autor:
Zimeng, Ye, Mark F, Bennett, Andrew, Neal, Joshua A, Laing, Martin K, Hunn, Thanomporn, Wittayacharoenpong, Marian, Todaro, Sheila K, Patel, Melanie, Bahlo, Patrick, Kwan, Terence J, O'Brien, Ingrid E, Scheffer, Samuel F, Berkovic, Piero, Perucca, Michael S, Hildebrand
Publikováno v:
Neurology.
Mosaic pathogenic variants restricted to brain are increasingly recognized as a cause of focal epilepsies. We aimed to identify a mosaic pathogenic variant and its anatomical gradient in brain DNA derived from trace tissue on explanted stereo-electro
Autor:
Leanne M C, Hays, Andrew, Udy, Alexios A, Adamides, James R, Anstey, Michael, Bailey, Judith, Bellapart, Kathleen, Byrne, Andrew, Cheng, D, Jamie Cooper, Katharine J, Drummond, Matthias, Haenggi, Stephan M, Jakob, Alisa M, Higgins, Philip M, Lewis, Martin K, Hunn, Robert, McNamara, David K, Menon, Lynne, Murray, Benjamin, Reddi, Tony, Trapani, Shirley, Vallance, Paul J, Young, Ramon, Diaz-Arrastia, Lori, Shutter, Patrick T, Murray, Gerard F, Curley, Alistair, Nichol
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 99
Monitoring and optimisation of brain tissue oxygen tension (PbtO
Autor:
Lindsay R. Ancelet, Kate W.R. Broadley, Ian F. Hermans, Sarrabeth Stone, Martin K. Hunn, Melanie J. McConnell, Kathryn J. Farrand, Astrid Authier
Publikováno v:
International Journal of Cancer. 136:2566-2578
Glioblastoma multiforme (GBM) is a highly malignant brain tumor with an extremely short time to relapse following standard treatment. Since recurrent GBM is often resistant to subsequent radiotherapy and chemotherapy, immunotherapy has been proposed
Publikováno v:
Immunotherapy. 8:387-389
High-grade glioma is associated with an extremely poor prognosis despite standard treatment with surgery, radiotherapy and chemotherapy. There is a pressing need to develop more effective treatments. Recent advances in immunotherapy for solid cancers
Autor:
Ian F. Hermans, Peter M. Ferguson, Martin K. Hunn, Christiane Ruedl, Cameron S. Field, Lindsay R. Ancelet
Publikováno v:
OncoImmunology, Vol 7, Iss 1 (2018)
Vaccine-mediated cancer treatment is unlikely to induce long-term survival unless suppressive mechanisms are overcome. Given the success of antibody-mediated immune checkpoint blockade in relieving regulation of endogenous anti-tumor T cell responses
Autor:
Katrina Sharples, Michael Findlay, Brigitta Mester, Marina Dzhelali, Olivier Gasser, Martin K. Hunn, Lindsay R. Ancelet, David Hamilton, Evelyn Bauer, Ian F. Hermans, Catherine Wood
Publikováno v:
Journal of Neuro-Oncology. 121:319-329
There is no standard treatment for recurrent glioblastoma multiforme (GBM). Retreatment with temozolomide (TMZ) is one treatment option. We reasoned this could be more effective if combined with a vaccine that preferentially targeted TMZ-resistant ce